文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

罗莎犬蔷薇与复方草药制剂糖浆对注意缺陷多动障碍患者的效果:多中心随机对照试验研究方案

The effect of Rosa canina L. and a polyherbal formulation syrup in patients with attention-deficit/hyperactivity disorder: a study protocol for a multicenter randomized controlled trial.
PubMed 文献 · Trials · 2022-05-23

该研究方案拟纳入90例符合DSM-5诊断标准的ADHD儿童和青少年,随机等分为三组:RC糖浆+哌甲酯、PHF糖浆+哌甲酯、安慰剂+哌甲酯,每组30例。糖浆剂量为每8小时5cc,哌甲酯剂量稳定维持8周。主要采用Conner问卷、CSI-4和气质问卷评估疗效,旨在探讨两种草药产品对ADHD临床表现的疗效和安全性。

要点

  • ADHD是儿童和青少年最常见的行为障碍,部分患者对现有药物治疗无应答或存在副作用。
  • 研究纳入90例ADHD患者,随机等分为RC+MP、PHF+MP和安慰剂+MP三组,每组30例。
  • 糖浆剂量为每8小时5cc,MP剂量稳定维持8周,采用Conner问卷、CSI-4和气质问卷评估。

核心结论

  • 该试验是首个探讨RC和PHF糖浆对ADHD儿童和青少年临床表现影响的研究,研究结果将为这些草药产品对ADHD临床表现的作用提供新见解。

研究设计与样本

  • 多中心随机对照试验研究方案,计划纳入90例基于DSM-5诊断标准的ADHD患者,随机等分为三组,每组30例:RC糖浆+MP组、PHF糖浆+MP组、安慰剂+MP组。

主要发现

  • 糖浆剂量为每8小时5cc,MP在研究期间维持稳定剂量8周。
  • Conner问卷由教师和家长在干预前及之后每4周完成;CSI-4和气质问卷在干预前及每4周完成,直至2个月。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is the most common behavioral disorder in childhood and adolescence. A number of these patients do not respond to the current pharmacological treatments and there may also be drug side effects. This study aims to determine the efficacy and safety of two herbal medicine products, including Rosa canina L. (RC) and a polyherbal formulation (PHF) syrup, on the clinical manifestations of ADHD in children and adolescents. METHODS: Ninety ADHD patients based on DSM-5 diagnostic criteria will be randomly assigned equally into three groups: (1) RC syrup + methylphenidate (MP), (2) PHF syrup + MP, and (3) placebo + MP according to the inclusion criteria (30 subjects in each group). The syrup dosage is 5cc every 8 h, and MP will have a stabilized dose for 8 weeks during the study. Moreover, Conner's questionnaires will be completed by the teacher and parents before the intervention and then every 4 weeks. Also, the Child Symptom Inventory-fourth edition (CSI-4) and temperament questionnaires will be completed before the intervention and every 4 weeks until 2 months. DISCUSSION: This trial is the first experiment to determine the effects of RC and PHF syrups on the clinical manifestations of ADHD in children and adolescents. Our findings provide new insight into the effect of these herbal products on the clinical manifestations of ADHD. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT20190923044855N1 . Registered on 14 January 2020. The trial was registered at https://www.irct.ir/ .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Golsorkhi H, Qorbani M, Kamalinejad M, et al. The effect of Rosa canina L. and a polyherbal formulation syrup in patients with attention-deficit/hyperactivity disorder: a study protocol for a multicenter randomized controlled trial. Trials. 2022. PMID: 35606864. doi:10.1186/s13063-022-06297-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。